• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

Managing Atopic Dermatitis Treatment Escalation in Pregnancy: Considerations and Approaches

Author(s):

Elizabeth Kiracofe, MD, FAAD,Jenny Murase, MD, FAAD

Drs Kiracofe and Murase provide clinical insights on treatment escalation practices for patients with atopic dermatitis who are pregnant.

Current Time 0:00
Duration 4:37
Loaded: 0%
Stream Type LIVE
Remaining Time 4:37
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected
    Related Videos
    1 expert in this video
    Balancing Effective AD Symptom Control with Long-Term Safety in New Therapies
    1 expert in this video
    Key Considerations for Evaluating Ruxolitinib Cream as a Treatment for Young Children
    1 expert in this video
    Supporting Caregivers in Successful Long-Term Atopic Dermatitis Management: The Role of Dermatologists
    1 expert in this video
    Challenges and Emerging Solutions in Treatment for Age Groups: Addressing Disease Control, Safety, and Usability
    1 expert in this video
    Challenges and Unmet Needs in Treating Pediatric Atopic Dermatitis
    2 experts in this video
    IL-17 Inhibitor Treatment Impact on Quality of Life in Psoriasis and Psoriatic Arthritis
    2 experts in this video
    Clinical Attributes of IL-17 Inhibitors in Psoriasis
    1 expert in this video
    Talking to Patients on Sunscreen Application and the Effects of Visible Light
    2 experts in this video
    Mechanism of Action Differences Among IL-17 Inhibitors
    2 experts in this video
    The Role of IL-17 in Psoriasis Pathogenesis
    Related Content
    Can BSZY Cream Reduce Symptoms of Facial Atopic Dermatitis?
    March 27th 2025

    Can BSZY Cream Reduce Symptoms of Facial Atopic Dermatitis?

    The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
    August 2nd 2024

    The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

    Unraveling Type 2 Inflammation in Skin Diseases
    March 26th 2025

    Unraveling Type 2 Inflammation in Skin Diseases

    The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
    July 1st 2024

    The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

    The Mycobiome Connection: How Fungi Influence AD
    March 24th 2025

    The Mycobiome Connection: How Fungi Influence AD

    Dupilumab and AD: Pediatric Ocular Adverse Effects
    March 20th 2025

    Dupilumab and AD: Pediatric Ocular Adverse Effects

    © 2025 MJH Life Sciences

    All rights reserved.